Who is ... Stephan Wimmi?

"I’m fascinated by how bacteria work and how they use little dynamic machines to be successful."


Dr. Stephan Wimmi is a molecular microbiologist at the Institute for Biological Physics (IBP) at the University of Cologne. His research explores how pathogenic bacteria dynamically organize molecular processes that enable them to interact with their environment, compete with other microorganisms, and adapt to changing conditions. By combining molecular microbiology with quantitative and biophysical and biochemical approaches, he seeks to understand bacterial behavior from individual molecular machines to single cells and developing microbial communities.
 

Research Focus

A central theme of Wimmi’s research is the spatial and temporal organization of bacterial secretion systems. These complex molecular machines enable bacteria to transport proteins across cellular membranes or directly into neighboring cells and play fundamental roles in bacterial communication, competition, and pathogenesis.

During his doctoral and postdoctoral research, Wimmi investigated the molecular function and regulation of the type III secretion system (T3SS), an injectisome used by many Gram-negative pathogens to deliver effector proteins into eukaryotic host cells. His work has focused particularly on how dynamic protein interactions and changes in subcellular localization regulate secretion and ensure that effector proteins are delivered at the right time and place.

At the IBP, he studied how type 4 pili, cellular appendages for cell to cell and surface interactions, effect micro colony formation and dynamics. 

More recently, Wimmi has expanded his research toward the opportunistic human pathogen Stenotrophomonas maltophilia. This bacterium is increasingly relevant in clinical settings, particularly in immunocompromised patients, due to its high intrinsic resistance to multiple antibiotics and its ability to coexist and compete with other bacterial pathogens.

Wimmi investigates how S. maltophilia coordinates two important survival strategies: type IV secretion system (T4SS)-mediated competition with neighboring bacteria and antibiotic efflux. By studying how these systems respond to environmental cues at the level of individual cells and developing microcolonies, he aims to uncover the molecular principles that enable bacteria to establish a local niche and persist during infection.

Selected Publications & Scientific Contributions

Wimmi’s research has contributed to a better understanding of how bacterial secretion systems dynamically regulate protein export.

In a first-author study published in Nature Communications in 2021, Wimmi and colleagues investigated how the type III secretion system of Yersinia enterocolitica responds to environmental conditions. They demonstrated that low extracellular pH induces the dynamic relocalization of cytosolic secretion-system components, thereby preventing premature protein secretion. The findings revealed how spatial reorganization of a molecular secretion machine enables bacteria to rapidly adapt secretion activity to environmental signals.

Building on this work, Wimmi was co-first author of a study published in Nature Microbiology in 2024 that investigated how effector proteins are recruited and transported to the bacterial injectisome. Using advanced approaches including proximity labeling and single-particle tracking super-resolution microscopy, the researchers showed that mobile cytosolic sorting-platform complexes interact with effector proteins and shuttle them toward the membrane-bound secretion machinery.

Together, these studies provided new insights into the dynamic molecular organization of bacterial secretion and established an important methodological and conceptual foundation for Wimmi’s current research. His work increasingly extends these principles from individual molecular complexes toward understanding how secretion, competition, and antimicrobial resistance are coordinated at the single-cell and microcolony levels.

Scientific Career & Recognition

Wimmi studied Biological Sciences at Kaiserslautern University of Technology before completing a Master’s degree in Molecular and Cellular Biology at Philipps University Marburg. His Master’s research at the Max Planck Institute for Terrestrial Microbiology focused on the spatial organization and development of Vibrio cholerae and Vibrio parahaemolyticus during the bacterial cell cycle.

He subsequently joined the group of Prof. Andreas Diepold at the Max Planck Institute for Terrestrial Microbiology for his doctoral research on the molecular function and regulation of the bacterial type III secretion system. He completed his PhD in 2021 with magna cum laude. During this period, he also undertook a DAAD-funded research exchange at Carnegie Mellon University in Pittsburgh, expanding his expertise in advanced imaging approaches.

Following postdoctoral research at the Max Planck Institute, Wimmi joined the group of Prof. Berenike Maier at the Institute for Biological Physics at the University of Cologne in 2022. Here, he broadened his research toward bacterial biophysics and the collective behavior of bacterial cells, initially investigating type IV pili interactions.

Since 2025, Wimmi has been supported by a DFG Walter Benjamin position at the Institute for Biological Physics. His project investigates how secretome and efflux dynamics change during the transition from individual bacterial cells to microcolonies, providing the foundation for his emerging independent research program.

Current Research & Funding

In 2026, Wimmi joined the CMMC as a Career Advancement Program (CAP) Group Leader. His CAP 48 research program, “Deciphering the Spatial-Temporal Regulation of Type IV Secretion-Mediated Bacterial Killing and Antibiotic Efflux Pumps in Stenotrophomonas maltophilia,” investigates the molecular strategies that enable this multidrug-resistant opportunistic pathogen to compete, colonize its local niche, and persist during infection.

A particular focus is the type IV secretion system, which S. maltophilia can use for contact-dependent killing of competing Gram-negative bacteria, including clinically relevant pathogens such as Klebsiella pneumoniae and Pseudomonas aeruginosa. In parallel, Wimmi investigates antibiotic efflux pumps that contribute to the bacterium’s intrinsic antimicrobial resistance.

By combining molecular microbiology, biochemistry, microscopy, and biophysical approaches, his group aims to determine how these systems are regulated in space and time and how they respond to changing environmental conditions. Ultimately, Wimmi’s research seeks to connect fundamental principles of bacterial cell biology with a better understanding of how multidrug-resistant pathogens establish themselves during polymicrobial infections.